New approaches in the treatment of HIV/AIDS – focus on maraviroc and other CCR5 antagonists

Treatment of HIV-1 infection has produced dramatic success for many patients. Nevertheless, viral resistance continues to limit the efficacy of currently available agents in many patients. The CCR5 antagonists are a new class of antiretroviral agents that target a necessary coreceptor for viral entr...

Descripción completa

Detalles Bibliográficos
Autores principales: Schlecht, Hans P, Schellhorn, Sarah, Dezube, Bruce J, Jacobson, Jeffrey M
Formato: Texto
Lenguaje:English
Publicado: Dove Medical Press 2008
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2504054/
https://www.ncbi.nlm.nih.gov/pubmed/18728830

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2504054/
https://www.ncbi.nlm.nih.gov/pubmed/18728830

Ejemplares similares